Xenon Pharmaceuticals (XENE) Restructuring Costs: 2024-2025
Historic Restructuring Costs for Xenon Pharmaceuticals (XENE) over the last 2 years, with Sep 2025 value amounting to $6.7 million.
- Xenon Pharmaceuticals' Restructuring Costs rose 47.36% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year change of. This contributed to the annual value of $20.7 million for FY2024, which is 43.69% up from last year.
- According to the latest figures from Q3 2025, Xenon Pharmaceuticals' Restructuring Costs is $6.7 million, which was up 11.66% from $6.0 million recorded in Q2 2025.
- In the past 5 years, Xenon Pharmaceuticals' Restructuring Costs registered a high of $6.7 million during Q3 2025, and its lowest value of $4.6 million during Q3 2024.
- Over the past 2 years, Xenon Pharmaceuticals' median Restructuring Costs value was $5.5 million (recorded in 2024), while the average stood at $5.6 million.
- Data for Xenon Pharmaceuticals' Restructuring Costs shows a peak YoY spiked of 47.36% (in 2025) over the last 5 years.
- Over the past 2 years, Xenon Pharmaceuticals' Restructuring Costs (Quarterly) stood at $5.5 million in 2024, then spiked by 47.36% to $6.7 million in 2025.
- Its Restructuring Costs stands at $6.7 million for Q3 2025, versus $6.0 million for Q2 2025 and $5.5 million for Q1 2025.